Science & Technology
Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R44HL165997-02
Award Ceiling
$2.2M
Award Floor
$2.2M
Close Date
Feb 28, 2026
Total Funding
$2.2M
Expected Awards
1
Posted Date
Mar 15, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-2R44HL165997-02
Description
SBIR Phase Phase II award: "Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis" awarded to Aplexis, Inc. in Wilmette, Illinois. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $2,202,674. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.